Form 4: Marimed Inc. President and CEO Jon R. Levine Reports Changes in Beneficial Ownership

Jon R. Levine, President and CEO of Marimed Inc., reports acquisition of restricted stock units (RSUs) and updates to his beneficial ownership of common stock.

Summary

• On April 2, 2024, Jon R. Levine, President and CEO of Marimed Inc., reported changes in his beneficial ownership of the company's securities.
• Levine acquired 69,110 Restricted Stock Units (RSUs) which convert to common stock on a one-for-one basis.
• The RSUs will vest over a three-year period, with one-third vesting one year from the grant date and one-sixth vesting every six months thereafter until April 2, 2027.
• Levine directly owns 20,229,020 shares of common stock.
• Levine indirectly owns 6,684,640 shares of common stock through the Jon Levine Family Trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard regulatory filing reporting changes in beneficial ownership. There is no indication of positive or negative sentiment.

Positives

• The acquisition of RSUs by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.

Management Comments

• The reporting person disclaims beneficial ownership of these securities held in trust, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Industry Context

This filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency into the holdings and transactions of company executives.

Stakeholder Impact

• Shareholders are informed about the changes in ownership by a key executive, which can influence investor sentiment.

Key Dates